Clinical trial
TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients
NCT01409733 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients
- Lead sponsor
- Heidelberg University
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stage iv melanoma patients with unresectable liver metastases